Related Experiment Video
Updated: Apr 6, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Community-acquired pneumonia: An overview
1Department of Medicine, Division of Infectious Diseases, McMaster University , Hamilton, Ontario , Canada.
Abstract:
Community-acquired pneumonia is still a significant cause of morbidity and mortality and is often misdiagnosed and inappropriately treated. Although it can be caused by a wide variety of micro-organisms, the pneumococcus, atypicals, such as Mycoplasma pneumoniae and Chlamydophila pneumoniae, Staphylococcus aureus and certain Gram-negative rods are the usual pathogens encountered. The site-of-care decision is critical in determining the site and type of care as well as the extent of diagnostic workup. Antimicrobial therapy should be started as soon as possible particularly in those requiring admission to hospital, but typically the physician does not know with any degree of certainty the identity of the etiologic pathogen. A number of national guidelines have been published to help the physician with this choice. The initial drug(s) can be modified if necessary if the pathogen and its antimicrobial susceptibility pattern becomes known. Adjunctive therapy such as pressors and fluid replacement are of value and macrolides appear to help as well, likely secondary to their immunomodulatory effects. Recent data also suggest a role for steroids.
Insights
Community-acquired pneumonia (CAP) poses significant health risks and is often misdiagnosed. Early antimicrobial treatment and supportive care, guided by national guidelines, are crucial for managing CAP effectively.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Community-acquired pneumonia (CAP) remains a major cause of illness and death.
- Accurate diagnosis and timely treatment of CAP are often challenging due to diverse pathogens.
- The choice of care setting and diagnostic approach significantly impacts patient outcomes.
Purpose of the Study:
- To review current understanding and management strategies for community-acquired pneumonia.
- To highlight challenges in pathogen identification and initial antimicrobial selection for CAP.
- To discuss the role of adjunctive therapies and emerging treatment considerations in CAP.
Main Methods:
- Review of existing literature and national guidelines on CAP management.
- Analysis of common pathogens responsible for CAP, including typical and atypical bacteria.
- Discussion of evidence supporting early antimicrobial administration and site-of-care decisions.
Main Results:
- Common CAP pathogens include Streptococcus pneumoniae, atypical bacteria (Mycoplasma, Chlamydophila), Staphylococcus aureus, and Gram-negative rods.
- Prompt initiation of antimicrobial therapy is vital, especially for hospitalized patients.
- Adjunctive therapies, such as fluid replacement, pressors, macrolides (due to immunomodulatory effects), and potentially steroids, show promise.
Conclusions:
- Effective CAP management requires prompt, guideline-directed antimicrobial therapy.
- Adjunctive treatments may improve outcomes in CAP patients.
- Further research into the role of steroids and immunomodulatory agents in CAP is warranted.
More Related Videos
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:14Atypical Pneumonia
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....